The purpose of the study is to assess Oxford Hip Score at baseline, at 2 months and at over 12 months.
Age ≥ 18 years old;
Definite diagnosis of iliopsoas tendinopathy due to conflict between the tendon and the prosthetic cup;
Failure of first-line conservative treatment;
Planned endoscopic tenotomy;
Revision total hip prosthesis, multiple operations prior to tenotomy;
Other surgical or medical interventions planned during the study;
Participation in another clinical trial, or during a period of exclusion from another clinical trial;
Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding;
GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead sponsor
Euraxi Pharma
Collaborator